SID 2026Abstract 0941
Reduction of skin CD8 TRMs in icotrokinra-treated participants with moderate-to-severe plaque psoriasis
Phase 3 ICONIC-LEAD results through week 52
Angsana J, Ren Y, Sendecki J, Kohler K, Roscoe N, Gooco J, Sisk C, Lee T, DeKlotz C, Miller-Kassamali M, Cafone J, Newbold P, Kannan A, Polak ME, Waterworth D, Sabins N, Cuff C, Eyerich K, Wolk K, Sabat R, Mehta H, Sarfati M, Molin S, Bissonnette R
SID Annual Meeting 2026Cell & molecular biologyChicago, 13–16 May 2026 · published in JID 21 Jul 2026
Topics: PsoriasisJAK inhibitors & other targeted pills
Abstract
The abstract’s text is on the JID website.
DOI 10.1016/j.jid.2026.06.972 · Not in PubMed: details from Crossref